Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
313 GBX | -0.63% | -5.15% | -11.21% |
Apr. 02 | MaxCyte inks deal with Be Bio; Orcadian firms farmout | AN |
Apr. 02 | MaxCyte, Inc. Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.21% | 409M | |
+2.02% | 209B | |
+2.17% | 177B | |
+10.45% | 133B | |
+16.62% | 99.89B | |
-2.70% | 61.83B | |
+13.38% | 52.51B | |
-6.33% | 45.54B | |
-4.74% | 39.43B | |
+9.89% | 38.87B |
- Stock Market
- Equities
- MXCT Stock
- News MaxCyte, Inc.
- MaxCyte Secures Strategic Platform License Deal; London Stocks Jump 7%